EGCG, the major polyphenol in green tea, may play a role in the battle against Alzheimer’s disease, according to researchers at McMaster University in Hamilton, Ontario.

Preclinical evidence suggests that EGCG “interferes with the formation of toxic assemblies (oligomers), one of the prime suspects in the early steps of the molecular cascade that leads to cognitive decline in Alzheimer’s patients,” the university reports.

Read the full article

Posted 10/18/2017

The preceding materials related to health information are provided for educational purposes only.
Tea and tea containing products are not intended to treat, cure or prevent any disease or illness. You should always consult a physician regarding the applicability of any information or recommendations with respect to any symptoms or medical condition.

Bigelow is not responsible for the content contained in third-party studies. Bigelow provides these studies for reference, and this does not represent an endorsement or responsibility for the content of such third-party studies.